Earlier this year, an executive at Dell Technologies announced his retirement and commitment to philanthropy. Just a few months later, he and his wife made a whopping donation to the Houston health care organization that's responsible for curing their son.| InnovationMap
The University of Texas MD Anderson Cancer Center and Nexo Therapeutics announced last week that they are collaborating, a move that could lead to the discovery of therapies that could work for patients with limited treatment options.| InnovationMap
Thanks in part to multimillion-dollar grants from the Cancer Prevention and Research Institute of Texas, two top-flight cancer researchers are taking key positions at Houston’s Baylor College of Medicine.| InnovationMap
The second quarter of 2023 looked a lot like the first when it came to venture capital funding for Houston companies. The whole country — affected by inflation, geopolitical instability, and other factors — has seen a trying time for investment opportunities.| InnovationMap
Four Houston bioscience startups have collected nearly $43 million in grants from the Cancer Prevention and Research Institute of Texas (CPRIT).| InnovationMap
Houston’s Baylor College of Medicine is beefing up its team of cancer researchers.| InnovationMap
7 Hills Pharma is announcing that last month, it was awarded a $13.5 million grant from the Cancer Prevention and Research Institute of Texas (CPRIT). That’s on top of more than $13 million in NIH grants, making the company the second largest recipient of SBIR/STTR grants in Texas.| InnovationMap
Houston’s University of Texas MD Anderson Cancer Center will establish a genomics research hub thanks to a nearly $3 million award from the Cancer Prevention and Research Institute of Texas, or CPRIT.| InnovationMap